Search





Search





Markets
/
Stocks
/
sprb
/

Spruce Biosciences Inc

SPRB

Add to Watchlist

42.830USD

-0.540-1.25%

Close 07-31 16:00（ET）Quotes delayed by 15 min

58.76MMarket Cap

LossP/E TTM

Spruce Biosciences Inc

42.830

-0.540-1.25%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

SPRB Financials

See Spruce Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Spruce Biosciences Inc Earnings Date

Latest Release

May 13, 2026

EPS / Forecast

-8.94/-8.82

Revenue / Forecast

--/0.00

See Upcoming Earnings >>

Period

FY2025 Earnings

Revenue(YoY)

-100.00%

EPS(YoY)

-50.83

47.27%

Analyst Rating

BUY

2026/08/01

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

Financial Indicators

EPS

62.69%-8.94

73.50%-11.28

7.37%-14.58

-1467.72%-262.25

-12.95%-23.96

-132.71%-42.58

30.82%-15.75

29.48%-16.73

29.45%-21.22

48.42%-18.30

---22.76

---23.72

---30.07

---35.47

---1.49

----

Revenue

----

-100.00%0.00

-75.86%697.00K

-80.41%602.00K

-25.64%1.61M

1.93%2.00M

--2.89M

--3.07M

--2.17M

--1.96M

----

Net Profit

12.64%-12.27M

37.83%-14.65M

5.29%-8.21M

77.49%-2.07M

-20.78%-14.04M

-136.77%-23.56M

29.81%-8.67M

28.41%-9.18M

9.12%-11.63M

10.71%-9.95M

-8.36%-12.35M

-8.02%-12.82M

-8.75%-12.79M

-21.34%-11.14M

0.40%-11.40M

-0.83%-11.87M

-18.96%-11.76M

-10.15%-9.18M

-19.40%-11.45M

---11.77M

Net Margin

----

-880.73%-3380.06%

-258.28%-1440.37%

3.73%-570.25%

10.84%-580.67%

---344.65%

---402.02%

---592.33%

---651.27%

----

Gross Margin

----

0.00%100.00%

--100.00%

----

Debt to assets ratio

170.81%11.51%

-100.00%0.00%

6.78%3.52%

28.24%4.32%

26.41%4.25%

20.23%3.86%

-0.28%3.30%

2.81%3.37%

3.40%3.36%

-44.02%3.21%

--3.31%

--3.28%

--3.25%

--5.74%

--5.14%

----

Income Statement

Revenue

----

-100.00%0.00

-75.86%697.00K

-80.41%602.00K

-25.64%1.61M

1.93%2.00M

--2.89M

--3.07M

--2.17M

--1.96M

----

Operating profit

17.29%-11.99M

53.89%-11.10M

12.53%-8.23M

73.18%-2.69M

-14.72%-14.49M

-115.64%-24.07M

31.12%-9.41M

28.17%-10.04M

4.29%-12.63M

7.81%-11.16M

-18.18%-13.66M

-17.59%-13.97M

-12.49%-13.20M

-32.57%-12.11M

-1.38%-11.56M

-1.43%-11.88M

-19.52%-11.73M

-9.60%-9.13M

-19.26%-11.40M

---11.71M

Net Profit

12.64%-12.27M

37.83%-14.65M

5.29%-8.21M

77.49%-2.07M

-20.78%-14.04M

-136.77%-23.56M

29.81%-8.67M

28.41%-9.18M

9.12%-11.63M

10.71%-9.95M

-8.36%-12.35M

-8.02%-12.82M

-8.75%-12.79M

-21.34%-11.14M

0.40%-11.40M

-0.83%-11.87M

-18.96%-11.76M

-10.15%-9.18M

-19.40%-11.45M

---11.77M

Balance Sheet

Current assets

79.98%55.03M

17.88%52.11M

-77.17%14.52M

-71.65%20.95M

-64.39%30.58M

-56.74%44.21M

-42.80%63.57M

-40.46%73.91M

-37.43%85.86M

22.22%102.18M

19.26%111.14M

28.62%124.13M

44.31%137.24M

-9.02%83.61M

-0.78%93.19M

-13.35%96.51M

-37.27%95.10M

-42.71%91.89M

27.61%93.92M

189.44%111.37M

Total current liabilities

-24.78%11.78M

-33.84%10.09M

-20.50%9.43M

-43.58%8.06M

-14.83%15.67M

-37.68%15.25M

-50.98%11.86M

-37.16%14.29M

-20.01%18.39M

96.55%24.46M

101.55%24.19M

125.04%22.73M

156.38%23.00M

40.31%12.45M

32.45%12.00M

44.73%10.10M

30.92%8.97M

-9.14%8.87M

-10.16%9.06M

10.18%6.98M

Total assets

77.47%56.17M

17.28%53.02M

-76.48%15.31M

-71.11%21.82M

-63.85%31.65M

-56.51%45.21M

-42.38%65.10M

-40.05%75.52M

-37.07%87.54M

21.36%103.95M

18.56%112.98M

20.52%125.96M

20.98%139.11M

-32.29%85.65M

-29.45%95.30M

-27.14%104.52M

-25.33%114.99M

-22.35%126.49M

72.12%135.09M

268.12%143.45M

Total liabilities

31.81%21.52M

-35.90%10.51M

-26.27%9.93M

-47.16%8.64M

-21.95%16.32M

-40.27%16.39M

-51.22%13.46M

-44.39%16.35M

-32.79%20.91M

59.87%27.44M

64.08%27.60M

90.99%29.40M

111.03%31.12M

13.54%17.16M

9.47%16.82M

15.38%15.39M

11.13%14.74M

12.33%15.12M

6.12%15.37M

38.66%13.34M

Total equity

126.10%34.65M

47.52%42.52M

-89.57%5.39M

-77.72%13.18M

-77.00%15.32M

-62.33%28.82M

-39.52%51.64M

-38.72%59.17M

-38.31%66.62M

11.71%76.51M

8.80%85.38M

8.35%96.56M

7.74%108.00M

-38.51%68.49M

-34.45%78.47M

-31.50%89.12M

-28.77%100.24M

-25.47%111.37M

87.05%119.72M

343.35%130.11M

Cash Flow Statement

Net operating income

31.39%-8.73M

68.78%-6.46M

42.36%-5.32M

20.51%-8.83M

14.92%-12.73M

-84.47%-20.68M

24.83%-9.22M

-657.25%-11.11M

-26.87%-14.96M

4.51%-11.21M

-43.03%-12.27M

120.89%1.99M

0.30%-11.79M

-19.79%-11.74M

-12.91%-8.58M

1.58%-9.54M

-34.59%-11.83M

-5.75%-9.80M

0.00%-7.60M

---9.69M

Net investment

---10.00K

----

-100.00%0.00

-36.17%9.30M

182.83%13.99M

-34.34%22.00M

239.95%10.48M

343.51%14.57M

-36.95%-16.89M

155.08%33.51M

-39326.32%-7.49M

-24829.17%-5.98M

-28586.05%-12.34M

---60.83M

Net financing

3485.89%13.92M

7251.04%44.69M

0.74%-402.00K

-9.59%-400.00K

-81.06%-411.00K

-13.22%-625.00K

0.00%-405.00K

15.51%-365.00K

-100.45%-227.00K

-1633.33%-552.00K

-350.00%-405.00K

-336.36%-432.00K

57519.32%50.53M

-78.44%36.00K

-629.41%-90.00K

-156.25%-99.00K

-131.10%-88.00K

-99.82%167.00K

-99.96%17.00K

--176.00K

FAQs

What are the current assets of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its current assets were 52.11M, with a year-on-year change of 17.88.

What are the total assets of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its total assets of Spruce Biosciences Inc were 53.02M, with a year-on-year change of 17.28.

What are the total liabilities of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its total liabilities of Spruce Biosciences Inc were 10.51M, with a year-on-year change of -35.90.

What is the total equity of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its total equity of Spruce Biosciences Inc was 42.52M, with a year-on-year change of 47.52.

What is the net operating income of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its net operating income of Spruce Biosciences Inc was -36.51M, with a year-on-year change of 34.97.

What is the net financing of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its net financing of Spruce Biosciences Inc was 43.48M, with a year-on-year change of 2780.70.

What is the Earnings Per Share (EPS) of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -50.83, with a year-on-year change of 47.27.

What is the net income of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its net income was -38.97M, with a year-on-year change of 26.53.

What is the Return on Equity (ROE) of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -109.24, with a year-on-year change of -8.48.

What is the Return on Assets (ROA) of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -79.34, with a year-on-year change of -11.56.

What is the operating profit of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its operating profit was -36.51M, with a year-on-year change of 34.97.